Fujian Cosunter Pharmaceutical Co (SZSE:300436) EPS (Basic) : ¥-1.07 (TTM As of Mar. 2025)

View and export this data going back to 2015. Start your Free Trial

What is Fujian Cosunter Pharmaceutical Co EPS (Basic)?

Fujian Cosunter Pharmaceutical Co's basic earnings per share (Basic EPS) for the three months ended in Mar. 2025 was ¥-0.18. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2025 was ¥-1.07.

Fujian Cosunter Pharmaceutical Co's EPS (Diluted) for the three months ended in Mar. 2025 was ¥-0.18. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was ¥-1.07.

Fujian Cosunter Pharmaceutical Co's EPS without NRI for the three months ended in Mar. 2025 was ¥-0.17. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2025 was -0.71.

During the past 3 years, the average EPS without NRI Growth Rate was -59.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Fujian Cosunter Pharmaceutical Co's highest 3-Year average EPS without NRI Growth Rate was 68.30% per year. The lowest was -221.40% per year. And the median was -53.50% per year.

Fujian Cosunter Pharmaceutical Co EPS (Basic) Historical Data

The historical data trend for Fujian Cosunter Pharmaceutical Co's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fujian Cosunter Pharmaceutical Co EPS (Basic) Chart

Fujian Cosunter Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

EPS (Basic)

Get a 7-Day Free Trial

0.11

-0.23

-0.80

-2.19

-0.98

Fujian Cosunter Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
EPS (Basic)	Get a 7-Day Free Trial															-0.09	-0.13	-0.22	-0.54	-0.18

Fujian Cosunter Pharmaceutical Co EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Fujian Cosunter Pharmaceutical Co's Basic EPS for the fiscal year that ended in Dec. 2024 is calculated as

Basic EPS (A: Dec. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-156.304	-	0)	/	159.267
	=	-0.98

Fujian Cosunter Pharmaceutical Co's Basic EPS for the quarter that ended in Mar. 2025 is calculated as

Basic EPS (Q: Mar. 2025 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-28.489	-	0)	/	159.245
	=	-0.18

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-1.07

Fujian Cosunter Pharmaceutical Co (SZSE:300436) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Fujian Cosunter Pharmaceutical Co EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Fujian Cosunter Pharmaceutical Co's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Fujian Cosunter Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Fujian Cosunter Pharmaceutical Co Ltd (SZSE:300436) » Definitions » EPS (Basic)

Traded in Other Exchanges

N/A

Address

Software Park, No. 89, Software Avenue, Block B, Building 10, Zone B, Gulou District, Fujian, Fuzhou, CHN, 350003

Website

http://www.cosunter.com

Fujian Cosunter Pharmaceutical Co Ltd is a pharmaceutical company engaged in the pharmaceutical production, sales and Research and Development. Its specialized in the field of hepatitis B medicine. Its product includes Fuganding-tenofovir disoproxil fumarate capsule, Enganding-Entecavir Capsules, He Ganding-Lamifuzed tablets and Agandan-adefovir dipivoxil tablets.

Executives

Li Guo Ping	Directors, executives
Huang Fu Hu	Directors, executives
Li Hong Ming	Directors, executives
Guan Jian Hui	Executives
Lin Xiao Hui	Directors, Directors, and Executives
Ye Li Qing	Director
Li Yuan Li	Supervisors
Zheng Li Feng	Supervisors
Li Guo Dong	Directors, executives

Fujian Cosunter Pharmaceutical Co Headlines

No Headlines